Lumantas, Kim Daniell F.
HRN: 21-53-02 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2022
CEFTRIAXONE 1G (VIAL)
07/09/2022
07/15/2022
IV DRIP
2 Grams
Q24
Seizure Disroder
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes